Abstract
Original language | English |
---|---|
Journal | Med. Oncol. |
Volume | 37 |
Issue number | 11 |
DOIs | |
Publication status | Published - 2020 |
Keywords
- Cancer radiotherapy
- COVID-19
- Lombardy
- Northern Italy
- Survey
- Article
- cancer radiotherapy
- control strategy
- coronavirus disease 2019
- emergency health service
- follow up
- health care facility
- health care survey
- health workforce
- human
- hypofractionated radiotherapy
- infection prevention
- Italy
- nurse
- occupational exposure
- outpatient care
- palliative therapy
- pandemic
- patient safety
- priority journal
- quarantine
- radiation oncologist
- radiation oncology
- radiological technologist
- radiology department
- social distancing
- teleconsultation
- therapy delay
- treatment duration
- treatment interruption
- virus transmission
- Betacoronavirus
- cancer center
- clinical trial
- Coronavirus infection
- health care personnel
- multicenter study
- neoplasm
- protective equipment
- questionnaire
- virus pneumonia
- Coronavirus Infections
- Health Personnel
- Humans
- Neoplasms
- Oncology Service, Hospital
- Pandemics
- Personal Protective Equipment
- Pneumonia, Viral
- Surveys and Questionnaires
Fingerprint
Dive into the research topics of 'Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2: Medical Oncology'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 : Medical Oncology. / Jereczek-Fossa, B.A.; Pepa, M.; Marvaso, G.; Isaksson, J.L.; Soatti, C.P.; Cazzaniga, L.F.; Ivaldi, G.B.; Amadori, M.; Antognoni, P.; Arcangeli, S.; Buffoli, A.; Beltramo, G.; Bignardi, M.; Bracelli, S.; Bruschieri, L.; Castiglioni, S.; Catalano, G.; Di Muzio, N.; Fallai, C.; Fariselli, L.; Filippi, A.R.; Gramaglia, A.; Italia, C.; Lombardi, F.; Magrini, S.M.; Nava, S.; Orlandi, E.; Pasinetti, N.; Sbicego, E.L.; Scandolaro, L.; Scorsetti, M.; Stiglich, F.; Tortini, R.; Valdagni, R.; Vavassori, V.; Tonoli, S.; Palazzi, M.F.; Lombardy), on behalf of the CODRAL (Board of Directors of Radiation Oncology Departments in Lombardy) network and of AIRO-L (Italian Association of Radiotherapy and Clinical Oncology -.
In: Med. Oncol., Vol. 37, No. 11, 2020.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2
T2 - Medical Oncology
AU - Jereczek-Fossa, B.A.
AU - Pepa, M.
AU - Marvaso, G.
AU - Isaksson, J.L.
AU - Soatti, C.P.
AU - Cazzaniga, L.F.
AU - Ivaldi, G.B.
AU - Amadori, M.
AU - Antognoni, P.
AU - Arcangeli, S.
AU - Buffoli, A.
AU - Beltramo, G.
AU - Bignardi, M.
AU - Bracelli, S.
AU - Bruschieri, L.
AU - Castiglioni, S.
AU - Catalano, G.
AU - Di Muzio, N.
AU - Fallai, C.
AU - Fariselli, L.
AU - Filippi, A.R.
AU - Gramaglia, A.
AU - Italia, C.
AU - Lombardi, F.
AU - Magrini, S.M.
AU - Nava, S.
AU - Orlandi, E.
AU - Pasinetti, N.
AU - Sbicego, E.L.
AU - Scandolaro, L.
AU - Scorsetti, M.
AU - Stiglich, F.
AU - Tortini, R.
AU - Valdagni, R.
AU - Vavassori, V.
AU - Tonoli, S.
AU - Palazzi, M.F.
AU - Lombardy), on behalf of the CODRAL (Board of Directors of Radiation Oncology Departments in Lombardy) network and of AIRO-L (Italian Association of Radiotherapy and Clinical Oncology -
N1 - Export Date: 3 March 2021 CODEN: MONCE Correspondence Address: Pepa, M.; Division of Radiation Oncology, Via Ripamonti, Italy; email: matteo.pepa@ieo.it Funding details: 5 × 1000 Funding text 1: JLI is a Ph.D. student within the European School of Molecular Medicine (SEMM), Milan, Italy. The authors wish to thank Mattia Zaffaroni MSc for his contribute to this work. IEO, the Institution of Authors BAJF, MP, GM and JLI, was also partially supported by the Italian Ministry of Health with Ricerca Corrente and 5 × 1000 funds. Funding text 2: JLI is a Ph.D. student within the European School of Molecular Medicine (SEMM), Milan, Italy. The authors wish to thank Mattia Zaffaroni MSc for his contribute to this work. IEO, the Institution of Authors BAJF, MP, GM and JLI,?was also partially supported by the Italian Ministry of Health with Ricerca Corrente and 5 ? 1000 funds. References: Jereczek-Fossa, B.A., Pepa, M., Marvaso, G., COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) (2020) Radiother Oncol., 149, pp. 89-93; Jereczek-Fossa, B.A., Palazzi, M.F., Soatti, C.P., COVID-19 outbreak and cancer radiotherapy disruption in Lombardy, Northern Italy (2020) Clin Oncol. (R Coll Radiol), 32 (7), pp. e160-e161; Liang, W., Guan, W., Chen, R., Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China (2020) Lancet Oncol., 21 (3), pp. 335-337; Dai, M., Liu, D., Liu, M., Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak (2020) Cancer Discov., 10 (6), pp. 783-791; Mohindra, P., Buckey, C.R., Chen, S., Sio, T.T., Rong, Y., Radiation therapy considerations during the COVID-19 pandemic: literature review and expert opinions (2020) J Appl Clin Med Phys., 21 (5), pp. 6-12; Kumar, D., Dey, T., Treatment delays in oncology patients during COVID-19 pandemic: a perspective (2020) J Glob Health., 10 (1), p. 010367; Barton, M.B., Jacob, S., Shafiq, J., Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012 (2014) Radiother Oncol., 112 (1), pp. 140-144; Zhang, D., Li, T., Wang, P., Experts consensus on epidemic prevention and control in radiotherapy centers during the COVID-19 outbreak: Experiences from Sichuan Province (2020) Clin Transl Radiat Oncol., 24, pp. 88-91; Documento Di Indirizzo per La Valutazione E La Gestione Del Rischio Dei Pazienti E Degli Operatori Nei Reparti Di Radioterapia Oncologica in Corso Di Diffusione Del COVID-19, , https://www.radioterapiaitalia.it/wp-content/uploads/2020/03/v-2-Documento-AIRO-COVID-19-24-03-2020.pdf, Accessed on July 24th, 2020; Initial Results of a Nationwide Physician Survey, 5/20/20., , https://www.astro.org/ASTRO/media/ASTRO/News%20and%20Publications/PDFs/ASTROCOVID19Survey1-ExecSummary.pdf, Accessed on July 24th, 2020; Slotman, B.J., Lievens, Y., Poortmans, P., Effect of COVID-19 pandemic on practice in European radiation oncology centers (2020) Radiother Oncol., 150, pp. 40-42; https://www.money.it/Proroga-stato-di-emergenza-31-gennaio-cosa-cambia, Accessed on October 15th 2020; Guckenberger, M., Belka, C., Bezjak, A., Practice recommendations for lung cancer radiotherapy during the COVID-19 Pandemic: an ESTRO-ASTRO consensus statement (2020) Int J Radiat Oncol Biol Phys., 107 (4), pp. 631-640; Liao, Z., Rivin Del Campo, E., Salem, A., Pang, Q., Liu, H., Lopez Guerra, J.L., Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak (2020) Lung Cancer, 146, pp. 230-235; Passaro, A., Addeo, A., Von Garnier, C., ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer (2020) ESMO Open, 5; Magrini, S.M., Borghetti, P., Filippi, A.R., Letter to the editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic (2020) Radiother Oncol., 147, pp. 229-230; Guckenberger, M., Belka, C., Bezjak, A., Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: an ESTRO-ASTRO consensus statement (2020) Radiother Oncol., 146, pp. 223-229; Alterio, D., Volpe, S., Marvaso, G., Head and neck cancer radiotherapy amid COVID-19 pandemic: report from Milan, Italy (2020) Head Neck, 42 (7), pp. 1482-1490; Thomson, D.J., Palma, D., Guckenberger, M., Practice recommendations for risk-adapted head and neck cancer radiation therapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement (2020) Int J Radiat Oncol Biol Phys., 107 (4), pp. 618-627; De Felice, F., Polimeni, A., Tombolini, V., The impact of Coronavirus (COVID-19) on head and neck cancer patients’ care (2020) Radiother Oncol., 147, pp. 84-85; Obek, C., Doganca, T., Argun, O.B., Kural, A.R., Management of prostate cancer patients during COVID-19 pandemic (2020) Prostate Cancer Prostatic Dis.; Coles, C.E., Aristei, C., Bliss, J., International guidelines on radiation therapy for breast cancer during the COVID-19 Pandemic (2020) Clin Oncol. (R Coll Radiol), 32 (5), pp. 279-281; de Azambuja, E., Trapani, D., Loibl, S., ESMO Management and treatment adapted recommendations in the COVID-19 era: breast cancer (2020) ESMO Open, 5; Han, K., Mendez, L., D’Souza, D., Management of gynecologic cancer: choosing radiotherapy wisely by 3 Southern Ontario academic centers during the COVID-19 pandemic (2020) Radiother Oncol., 151, pp. 15-16; Siavashpour, Z., Taghizadeh-Hesary, F., Rakhsha, A., Recommendations on management of locally advanced rectal cancer during the COVID-19 pandemic: an Iranian consensus (2020) J Gastrointest Cancer.; Jones, C.M., Radhakrishna, G., Aitken, K., Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position (2020) Br J Cancer.; Catanese, S., Pentheroudakis, G., Douillard, J.Y., Lordick, F., ESMO management and treatment adapted recommendations in the COVID-19 era: pancreatic cancer (2020) ESMO Open, 5; Tchelebi, L.T., Haustermans, K., Scorsetti, M., Recommendations for the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19 (2020) Radiother Oncol., 148, pp. 194-200; Vavassori, A., Tagliaferri, L., Vicenzi, L., Practical indications for management of patients candidate to Interventional and Intraoperative Radiotherapy (Brachytherapy, IORT) during COVID-19 pandemic—a document endorsed by AIRO (Italian Association of Radiotherapy and Clinical Oncology) Interventional Radiotherapy Working Group (2020) Radiother Oncol., 149, pp. 73-77; Wang, W., Hu, K., Qiu, J., Zhang, F., Radiotherapy after the easing of public restrictions during COVID-19 epidemic (2020) Radiat Oncol., 15 (1), p. 166; Portaluri, M., Barba, M.C., Musio, D., Tramacere, F., Pati, F., Bambace, S., Hypofractionation in COVID-19 radiotherapy: a mix of evidence based medicine and of opportunities (2020) Radiother Oncol., 150, pp. 191-194; Barra, S., Guarnieri, A., di Bastia, M.B.M.E., Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice (2020) Radiol Med.; Faivre-Finn, C., Fenwick, J.D., Franks, K.N., Reduced fractionation in lung cancer patients treated with curative-intent radiotherapy during the COVID-19 pandemic (2020) Clin Oncol. (R Coll Radiol), 32 (8), pp. 481-489; Nagar, H., Formenti, S.C., Cancer and COVID-19 – potentially deleterious effects of delaying radiotherapy (2020) Nat Rev Clin Oncol., 17 (6), pp. 332-334
PY - 2020
Y1 - 2020
N2 - Background: Italy experienced one of the world’s severest COVID-19 outbreak, with Lombardy being the most afflicted region. However, the imposed safety measures allowed to flatten the epidemic curve and hence to ease the restrictions and inaugurate, on the 4th of May 2020, the Italian phase (P) 2 of the pandemic. The present survey study, endorsed by CODRAL and AIRO-L, aimed to assess how radiotherapy (RT) departments in Lombardy have dealt with the recovery. Materials and methods: A questionnaire dealing with the management of pandemic was developed online and sent to all CODRAL Directors on the 10th of June 2020. Answers were collected in full anonymity one week after. Results: All the 33 contacted RT facilities (100%) responded to the survey. Despite the scale of the pandemic, during P1 14 (42.4%) centres managed to safely continue the activity (≤ 10% reduction). During P2, 10 (30.3%) centres fully recovered and 14 (42.4%) reported an increase. Nonetheless, 6 (18.2%) declared no changes and, interestingly, 3 (9.1%) reduced activities. Overall, 21 centres (63.6%) reported suspected or positive cases within healthcare workforce since the beginning of the pandemic. Staff units were quarantined in 19 (57.6%) and 6 (18.2%) centres throughout P1 and P2, respectively. In the two phases, about two thirds centres registered positive or suspected cases amongst patients. Conclusion: The study revealed a particular attention to anti-contagion measures and a return to normal or even higher clinical workload in most RT centres in Lombardy, necessary to carry out current and previously deferred treatments. © 2020, Springer Science+Business Media, LLC, part of Springer Nature.
AB - Background: Italy experienced one of the world’s severest COVID-19 outbreak, with Lombardy being the most afflicted region. However, the imposed safety measures allowed to flatten the epidemic curve and hence to ease the restrictions and inaugurate, on the 4th of May 2020, the Italian phase (P) 2 of the pandemic. The present survey study, endorsed by CODRAL and AIRO-L, aimed to assess how radiotherapy (RT) departments in Lombardy have dealt with the recovery. Materials and methods: A questionnaire dealing with the management of pandemic was developed online and sent to all CODRAL Directors on the 10th of June 2020. Answers were collected in full anonymity one week after. Results: All the 33 contacted RT facilities (100%) responded to the survey. Despite the scale of the pandemic, during P1 14 (42.4%) centres managed to safely continue the activity (≤ 10% reduction). During P2, 10 (30.3%) centres fully recovered and 14 (42.4%) reported an increase. Nonetheless, 6 (18.2%) declared no changes and, interestingly, 3 (9.1%) reduced activities. Overall, 21 centres (63.6%) reported suspected or positive cases within healthcare workforce since the beginning of the pandemic. Staff units were quarantined in 19 (57.6%) and 6 (18.2%) centres throughout P1 and P2, respectively. In the two phases, about two thirds centres registered positive or suspected cases amongst patients. Conclusion: The study revealed a particular attention to anti-contagion measures and a return to normal or even higher clinical workload in most RT centres in Lombardy, necessary to carry out current and previously deferred treatments. © 2020, Springer Science+Business Media, LLC, part of Springer Nature.
KW - Cancer radiotherapy
KW - COVID-19
KW - Lombardy
KW - Northern Italy
KW - Survey
KW - Article
KW - cancer radiotherapy
KW - control strategy
KW - coronavirus disease 2019
KW - emergency health service
KW - follow up
KW - health care facility
KW - health care survey
KW - health workforce
KW - human
KW - hypofractionated radiotherapy
KW - infection prevention
KW - Italy
KW - nurse
KW - occupational exposure
KW - outpatient care
KW - palliative therapy
KW - pandemic
KW - patient safety
KW - priority journal
KW - quarantine
KW - radiation oncologist
KW - radiation oncology
KW - radiological technologist
KW - radiology department
KW - social distancing
KW - teleconsultation
KW - therapy delay
KW - treatment duration
KW - treatment interruption
KW - virus transmission
KW - Betacoronavirus
KW - cancer center
KW - clinical trial
KW - Coronavirus infection
KW - health care personnel
KW - multicenter study
KW - neoplasm
KW - protective equipment
KW - questionnaire
KW - virus pneumonia
KW - Coronavirus Infections
KW - Health Personnel
KW - Humans
KW - Neoplasms
KW - Oncology Service, Hospital
KW - Pandemics
KW - Personal Protective Equipment
KW - Pneumonia, Viral
KW - Surveys and Questionnaires
U2 - 10.1007/s12032-020-01434-1
DO - 10.1007/s12032-020-01434-1
M3 - Article
VL - 37
JO - Med. Oncol.
JF - Med. Oncol.
SN - 1357-0560
IS - 11
ER -